Back to Search
Start Over
microRNA-29b prevents renal fibrosis by attenuating renal tubular epithelial cell–mesenchymal transition through targeting the PI3K/AKT pathway
- Source :
- International Urology and Nephrology
- Publication Year :
- 2021
- Publisher :
- Springer Netherlands, 2021.
-
Abstract
- Purpose This study aimed to investigate the effects of miR-29b on renal interstitial fibrosis in the obstructed kidney of mouse with unilateral ureteral obstruction (UUO) via inhibiting phosphatidylinositol 3-kinase/protein kinaseB (PI3K/AKT) signaling pathway. Methods Adult male CD-1 mice were intraperitoneally injected with vehicle or PI3K inhibitor LY294002 (3 mg/kg, 30 mg/kg) daily for 1 or 2 weeks after performing UUO or sham operation. The mice were sacrificed on days 7 and 14 after surgery. The rat proximal tubular epithelial cell (TEC) line NRK-52E was cultured in DMEM and treated with various concentrations angiotensin II (AngII). Obstructed and sham mouse kidneys were analyzed via HE, Masson and immunohistochemistry to assess the degree of renal fibrosis. Real-time quantitative polymerase chain reaction assays (RT-PCR) were performed to investigate changes in the levels of expression of miR-29b and Western blot was used to analyze the activation of PI3K/AKT signaling and expression of E-cadherin, α-smooth muscle actin (α-SMA). Results Histologic analyses of obstructed kidney revealed that LY294002 attenuated the degree of renal fibrosis. In this study, loss of miR-29b accompanied with increased epithelial–mesenchymal transition (EMT) was observed in renal tubules of mice after UUO and cultured NRK-52E cells exposed to AngII. LY294002 also prominently decreased phosphorylation of AKT in vivo and vitro. By RT-PCR and Western blot analysis, LY294002 blocked the PI3K/AKT-induced loss of E-cadherin expression and de novo increase of the expression of α-SMA in a time- and dose-dependent manner. The overexpression of miR-29b markedly reversed the phenotype induced by AngII in NRK-52E cells and the downregulation miR-29b expression with an miR-29b inhibitor resulted in enhanced EMT. In addition, the PI3K/AKT signaling pathway was found to be suppressed in the presence of overexpression of miR-29b by direct hybridization with 3′-untranslated region (3′-UTR) of PIK3R2. Conclusion Our findings suggested that miR-29b significantly prevented tubulointerstitial injury in mouse model of UUO by attenuating renal tubular epithelial cell–mesenchymal transition via repressing PI3K/AKT signaling pathway.
- Subjects :
- 0301 basic medicine
Nephrology
Male
medicine.medical_specialty
Epithelial-Mesenchymal Transition
Urology
MicroRNA-29b
Kidney
03 medical and health sciences
Mice
Phosphatidylinositol 3-Kinases
0302 clinical medicine
Internal medicine
Phosphatidylinositol 3-kinase/protein kinase B
medicine
Renal fibrosis
Nephrology - Original Paper
Animals
Epithelial–mesenchymal transition
Protein kinase B
PI3K/AKT/mTOR pathway
Cells, Cultured
business.industry
Akt/PKB signaling pathway
NRK-52E cells
Angiotensin II
Fibrosis
Rats
MicroRNAs
030104 developmental biology
medicine.anatomical_structure
Kidney Tubules
030220 oncology & carcinogenesis
Cancer research
Angiotensin-II
Unilateral ureteral obstruction
Urothelium
business
Proto-Oncogene Proteins c-akt
Subjects
Details
- Language :
- English
- ISSN :
- 15732584 and 03011623
- Volume :
- 53
- Issue :
- 9
- Database :
- OpenAIRE
- Journal :
- International Urology and Nephrology
- Accession number :
- edsair.doi.dedup.....7ed9135da4bb663e5414c7bc409f904b